TREM2 and Parkinson disease: Homozygous loss-of-function mutations in TREM2 seem to be a vital risk factor for late-onset Alzheimer’s disease (85), and a significant association has been reported between TREM2 and Parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia (86–88).